Clinical Trial Update: Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice

View source ↗

Summary

An observational study completed in routine clinical practice evaluating the efficacy, safety and convenience of Mixtard 30 NovoLet used alone or with oral hypo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Mixtard 30 NovoLet (insulin human premixed 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED